RO60 and systemic sclerosis: Lastly, the elevated pre-diagnostic RNAP III autoantibodies were not elevated in the same SSc/SRC cases with elevated Ro52 and Ro60 autoantibodies supporting the idea that there are multiple pathogenic pathways to the development of SRC.